These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review. Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296 [TBL] [Abstract][Full Text] [Related]
4. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection. Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699 [TBL] [Abstract][Full Text] [Related]
5. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015 [TBL] [Abstract][Full Text] [Related]
6. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841 [TBL] [Abstract][Full Text] [Related]
7. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359 [TBL] [Abstract][Full Text] [Related]
9. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach. Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A Front Immunol; 2020; 11():1663. PubMed ID: 32754160 [TBL] [Abstract][Full Text] [Related]
10. Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an Kumar A; Kumar P; Saumya KU; Kapuganti SK; Bhardwaj T; Giri R Expert Rev Vaccines; 2020 Sep; 19(9):887-898. PubMed ID: 32815406 [TBL] [Abstract][Full Text] [Related]
11. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. Ahammad I; Lira SS Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237 [TBL] [Abstract][Full Text] [Related]
12. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches. Dong R; Chu Z; Yu F; Zha Y Front Immunol; 2020; 11():1784. PubMed ID: 32849643 [TBL] [Abstract][Full Text] [Related]
13. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069 [TBL] [Abstract][Full Text] [Related]
14. A candidate multi-epitope vaccine against SARS-CoV-2. Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763 [TBL] [Abstract][Full Text] [Related]
15. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis. Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372 [TBL] [Abstract][Full Text] [Related]
17. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Ahmed SF; Quadeer AA; McKay MR Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567 [TBL] [Abstract][Full Text] [Related]
18. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach. Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041 [TBL] [Abstract][Full Text] [Related]
19. The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650. Su QD; Yi Y; Zou YN; Jia ZY; Qiu F; Wang F; Yin WJ; Zhou WT; Zhang S; Yu PC; Bi SL; Shen LP; Wu GZ Vaccine; 2020 Jul; 38(32):5071-5075. PubMed ID: 32513514 [TBL] [Abstract][Full Text] [Related]